Low-dose interleukin-2 therapy: A promising targeted therapeutic approach for systemic lupus erythematosus

Reza Akbarzadeh, Gabriela Riemekasten, Jens Y. Humrich*

*Corresponding author for this work

Fingerprint

Dive into the research topics of 'Low-dose interleukin-2 therapy: A promising targeted therapeutic approach for systemic lupus erythematosus'. Together they form a unique fingerprint.

Medicine & Life Sciences